The antibody cocktail from Regeneron Pharmaceuticals that was administered to President Donald Trump for his Covid-19 infection last Friday as a "cure" for the deadly virus was developed using cells from aborted fetus, a practice that Trump and his supporters have repeatedly denounced over the years.
On Wednesday, just hours after Trump hailed the medication as a "cure" for the virus, Regeneron revealed that it had sent an application to the Food and Drug Administration (FDA) for an emergency drug authorization, which is a cocktail combination of two antibodies created to help the immune system battle the virus. He mistakenly said the drug was called Regeneron. The cocktail of monoclonal antibodies an experimental therapeutic for coronavirus which is still in the trial phase and has not been approved by the Food and Drug Administration (FDA) yet.
He was cautious about broader use without more data.
"I think this was a blessing from God, that I caught it. "This was a blessing in disguise."I caught it, I heard about this drug, I said let me take it, it was my suggestion".
Trump's move is seen as an attempt to show leadership amid criticism over the spread of the virus in the administration ahead of the presidential election in early November.
Anthony Fauci, the longtime director of the National Institute of Allergies and Infectious Disease, gave an interview to CBS News on Friday where he also referred to the coronavirus outbreak at the White House that infected dozens of people as a "super spreader event".
Regeneron has received $450 million from the USA government for up to 300,000 doses of the dual-antibody cocktail, and the company has said those supplies would be distributed free of charge.
The experimental therapy is 1 of several monoclonal antibody treatments in testing that may help treat patients with COVID-19.
The treatment has come under the spotlight after Trump was treated with Regeneron Pharmaceuticals' REGN.O antibody drug last week. Lilly's shares rose 3.4% on Wednesday to close at $148.96.